Aduro Biotech Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

    NEXT STORY
    Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
    PREV STORY
    Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cytori Reports Sustained Benefit of Cell Therapy in Erectile Dysfunction Trial

    Benefit Observed at 12 months Postoperatively Following Single AdministrationSAN DIEGO, July 09, 2018 (GLOBE ...

    author_avatar
    NASDAQ Market News

    Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub

    author_avatar
    NASDAQ Market News

    Galectin Therapeutics Appoints Dr. Marc Rubin Chairman of the Board of Directors

    NORCROSS, Ga., Jan. 08, 2016 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading ...

    author_avatar
    NASDAQ Market News